Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial.
Saved in:
| Title: | Sex differences in response to the endothelin receptor antagonist atrasentan in individuals with type 2 diabetes and chronic kidney disease: a post hoc analysis of the SONAR trial. |
|---|---|
| Authors: | Smeijer JD; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., de Vries ST; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Kohan DE; Division of Nephrology, School of Medicine, University of Utah Health, Salt Lake City, UT, USA., Hou FF; Division of Nephrology, Nanfang Hospital, Southern Medical University, National Clinical Research Center for Kidney Disease, Guangzhou, China., Heerspink HJL; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. h.j.lambers.heerspink@umcg.nl.; George Institute for Global Health, Sydney, NSW, Australia. h.j.lambers.heerspink@umcg.nl. |
| Source: | Diabetologia [Diabetologia] 2025 Mar; Vol. 68 (3), pp. 516-525. Date of Electronic Publication: 2024 Dec 11. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0428 |
|---|---|
| DOI: | 10.1007/s00125-024-06326-x |
